Top SitesHome | PhRMA

Machine Readiness

Stored receipt and evidence

Overall

20

Readable

65

Callable

0

Commerce

0

Payment

0

Machine Access

Inspect the site's MCP endpoint

Open MCP explorer

DialtoneApp can scan the stored discovery files for this domain, try the MCP initialize handshake, and show the raw protocol transcript.

Purchase boundary

read only

Control boundary

unknown

Payment rails

None

Payment providers

None

Payment methods

None

Payment protocols

None

Payment assets

None

Payment networks

None

Capabilities

None

Verified payment surface

No

Crypto only

No

Readable docs

robots, llms

Products

0

Variants

0

Priced variants

0

Currencies

0

Offers

0

Priced offers

0

Priced actions

0

Samples

Offer samples

No stored offer samples.

Samples

Action samples

No stored action samples.

Samples

Product samples

No stored product samples.

Document

robots.txt

Open robots.txt
User-agent: *
Allow: /
Disallow: /api/
Disallow: /error/
Disallow: /admin/
Disallow: /preview/
Disallow: */More%20Than%20Half%20of%20Every%20Dollar%20Spent%20on%20Medicines%20Goes%20to%20Someone%20Who%20Doesnt%20Make%20Them%204ALT.pdf

# Sitemap
Sitemap: https://phrma.org/sitemap.xml 

Document

llms.txt

Open llms.txt
# phrma.org llms.txt

> PhRMA (Pharmaceutical Research and Manufacturers of America) represents the country’s leading innovative biopharmaceutical research companies. This site contains resources on drug development policy, patient access to pharmaceuticals, public policy advocacy, and health care industry data.

## Core Mission & Agenda
- [About PhRMA](https://phrma.org/about ): Overview of PhRMA’s mission, vision, and role in the biopharmaceutical industry.
- [Our Agenda](https://phrma.org/our-agenda ): A summary of the organization's legislative and policy priorities, including reining in middlemen and insurers, stopping 340B program abuse, and protecting the U.S. from harms of government drug price setting.
- [Ethics Codes & Guidelines](https://phrma.org/about/ethics-codes-guidelines ): The ethical framework governing member companies and clinical trials.

## Research & Innovation
- [Innovation Ecosystem](https://phrma.org/policy-issues/innovation-ecosystem ): Explains American's leadership in medicine development, and the need for supportive public policies to sustain research, development, and patient access.
- [Research & Development Policy](https://phrma.org/policy-issues/research-development ): Explains the drug R&D process, investment costs, and science behind new and innovative therapies.
- [Government Price Setting](https://phrma.org/policy-issues/government-price-setting): Explains why most-favored nation drug pricing does not fix drug costs.
- [Intellectual Property](https://phrma.org/policy-issues/intellectual-property ): The role of patents in sustaining innovation and lowering drug costs.
- [Vaccines](https://phrma.org/policy-issues/innovative-medicines/vaccines): What vaccines are, how they work and their role in public health. 

## Patient Access & Affordability
- [PBMs & Middlemen](https://phrma.org/policy-issues/pbms-middlemen ): Advocacy regarding Pharmacy Benefit Managers and middleman markups.
- [Hospitals & 340B](https://phrma.org/policy-issues/340b ): PhRMA’s position on the 340B drug program.


## Data, Reports & Resources
- [PhRMA Resources & Data](https://phrma.org/resources): Library of links, press releases, white papers, fact sheets, and economic reports.
- [Blog](https://phrma.org/blog ): Access the latest information, articles and updates here.

## Leadership
- [Leadership Team](https://phrma.org/about/leadership ): Profiles of the executive team and board of directors.

Document

llms-full.txt

Not stored for this site.